Palatin Technologies, Inc. (PTN)
AMEX·Healthcare·Biotechnology
$5.39
+7.92%
Mkt Cap $291.52M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$47.50
Range $47.50 – $47.50
Implied Upside
+782.1%
Consensus $47.50 vs current $5.39
AMEX·Healthcare·Biotechnology
$5.39
+7.92%
Mkt Cap $291.52M
No recent rating data.
Price Target (3 analysts)
$47.50
Range $47.50 – $47.50
+782.1%
Consensus $47.50 vs current $5.39